EPO and anemia (phenotype): In clinical practice, recombinant human erythropoietin (rHuEPO) is used to treat anemia associated with chronic kidney disease, chemotherapy-induced anemia in cancer patients, and anemia in patients with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) (2–4).